This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
OKYO Pharma Gestione
Gestione criteri di controllo 1/4
Informazioni chiave
Gary Jacob
Amministratore delegato
UK£1.5m
Compenso totale
| Percentuale dello stipendio del CEO | 17.5% |
| Mandato del CEO | 2.3yrs |
| Proprietà del CEO | 0.05% |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 2.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?
Nov 26
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?
Jan 27Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation
Sep 22We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth
Mar 17We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow
Dec 02Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -UK£7m |
| Jun 30 2022 | n/a | n/a | -UK£5m |
| Mar 31 2022 | UK£1m | UK£256k | -UK£4m |
| Dec 31 2021 | n/a | n/a | -UK£4m |
| Sep 30 2021 | n/a | n/a | -UK£4m |
| Jun 30 2021 | n/a | n/a | -UK£3m |
| Mar 31 2021 | UK£649k | UK£61k | -UK£3m |
Compensazione vs Mercato: Gary's total compensation ($USD1.82M) is above average for companies of similar size in the UK market ($USD352.33K).
Compensazione vs guadagni: Gary's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
Gary Jacob (75 yo)
2.3yrs
Mandato
UK£1,467,000
Compensazione
Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | 2.3yrs | UK£1.47m | 0.049% £ 11.4k | |
| Founder | no data | Nessun dato | Nessun dato | |
| Chief Financial Officer | 2.8yrs | Nessun dato | 0% £ 0 | |
| Chief Scientific Officer | 2.2yrs | Nessun dato | 0% £ 0 |
2.3yrs
Durata media
64yo
Età media
Gestione esperta: OKYO's management team is considered experienced (2.3 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | 2.3yrs | UK£1.47m | 0.049% £ 11.4k | |
| Independent Non-Executive Director | 1.4yrs | UK£14.00k | Nessun dato | |
| Non-Executive Chairman | 2.3yrs | UK£120.00k | 33.47% £ 7.8m | |
| Independent Non-Executive Director | 2.9yrs | UK£55.00k | 0% £ 0 | |
| Member of Scientific Advisory Board | less than a year | Nessun dato | Nessun dato | |
| Senior Independent Non-Executive Director | 7.5yrs | UK£35.00k | 0.019% £ 4.3k | |
| Member of Scientific Advisory Board | 2.8yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
2.3yrs
Durata media
71yo
Età media
Consiglio di amministrazione esperto: OKYO's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.